Trademark Search in Canada

KADMON

View On IC.GC.CA

REGISTERED

on 12 Jan 2024

Last Applicant/ Owned by

KADMON CORPORATION LLC

450 East 29th StreetNEW YORK NY 10016

Serial Number

2053638 filed on 11^th Aug 2020

Registration Number

TMA1217935 registered on 12^th Jan 2024

Registration expiry Date

11^th Aug 2030

Correspondent Address

FASKEN MARTINEAU DUMOULIN S.E.N.C.R.L., SRL

365, rue Abraham-Martinbureau 600Québec

QUEBEC

G1K8N2

KADMON

Trademark usage description

pharmaceuticals and pharmaceutical preparations for use in treating cancer, immunologic disorders and viruses, namely, cytomegalovirus (cmv), retiniti Read More

Classification Information

Class [005]
Pharmaceuticals and pharmaceutical preparations for use in treating cancer, immunologic disorders and viruses, namely, cytomegalovirus (CMV), retinitis, pneumonia and Respiratory syncytial virus (RSV).

Classification kind code

Mark Details

Serial Number

2053638

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 30^th Mar 2022	Agent Changed
Submitted for opposition 22 on 12^th Jan 2022	Search Recorded
Submitted for opposition 20 on 12^th Jan 2022	Examiner's First Report
Submitted for opposition 223 on 12^th Jan 2022	Total Provisional Refusal
Submitted for opposition 256 on 26^th Jul 2021	Notification of Possible Opposition Sent
Submitted for opposition 257 on 24^th Sept 2020	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 23^rd Sept 2020	Formalized
Submitted for opposition 1 on 23^rd Sept 2020	Created
Submitted for opposition 228 on 11^th Aug 2020	International Registration
Submitted for opposition 30 on 11^th Aug 2020	Filed

KADMON

Classification Information

Class [005]Pharmaceuticals and pharmaceutical preparations for use in treating cancer, immunologic disorders and viruses, namely, cytomegalovirus (CMV), retinitis, pneumonia and Respiratory syncytial virus (RSV).

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceuticals and pharmaceutical preparations for use in treating cancer, immunologic disorders and viruses, namely, cytomegalovirus (CMV), retinitis, pneumonia and Respiratory syncytial virus (RSV).